Intellectual properties

MAMMALIAN MUSCLE-DERIVED STEM CELLS WO2015091210 A1

The present invention provides a new method of obtaining muscle-derived mesenchymal stem cells from micro-biopsies of mammalian origin. The invention provides for a minimally invasive methodology yielding high amounts of MSCs that can differentiate into different cell lineages

See Patent Details

NEW USES OF MAMMALIAN MUSCLE-DERIVED STEM CELLS WO2018189121

The present invention relates to a method for assessing the effects of a compound or composition on a mammal, comprising obtaining mammalian pluripotent muscle-derived mesenchymal stem cells or a population thereof, exposing the said stem cells, stem cell population to the relevant compound or composition, and assessing the effects on the said cells. The invention method is a reliable assessment method applicable to drug development, toxicity testing and optimized personalized medicine.

See Patent Details

METHOD FOR OBTAINING DIFFERENTIATED CELLS FROM MUSCLE DERIVED PROGENITOR CELLS WO2018189124

The present invention relates to a method for preparing differentiated mammalian cells comprising collecting muscle microbiopsy, placing the sample in a cell culture medium, collecting and growing the cells and differentiating them in suitable differentiation medium.

See Patent Details

MULTI-SITE PRODUCTION SYSTEM AND METHOD WO2018077900

The invention relates to a multi-site production system for production of a product under regulated conditions comprising at least two production sites (12) linked to a central monitoring unit (10), each production site (12) comprising at least one production unit (16) for production under regulated conditions and a computerized control unit (14) designed to receive, possibly record, and transfer required product and/or process parameters to the central monitoring unit (10) designed to check for validation purposes the production process and/or product quality. The invention further relates to a method for multi-site production under regulated conditions making use of above system.

See Patent Details

RevaTis Belgium Head Office

Rue de la Science, 8,

6900 Aye,

Belgium

info@revatis.com

RevaTis Dubai - United Emirates

Dubai Science Park

RevaTis AM - Texas - USA

RevaTis AM, Inc.

501 Graham Road

College Station, TX 77845

(979) 820-2441

info@revatisam.com

 

 

 

RevaTis Hong Kong

CWCC

Suites 1201-4, 12/F, Tower 2
The Gateway, 25-27 Canton Road
Tsim Sha Tsui, Kowloon,

Hong Kong